Application 209946
- Type
- ANDA
- Sponsor
- ZHEJIANG JINGXIN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | COLESEVELAM HYDROCHLORIDE | COLESEVELAM HYDROCHLORIDE | TABLET;ORAL | 625MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209946-001 | COLESEVELAM HYDROCHLORIDE | COLESEVELAM HYDROCHLORIDE | 625MG | TABLET / ORAL | AB | 2020-07-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209946-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209946-001 | COLESEVELAM HYDROCHLORIDE | 625MG | TABLET / ORAL | AB | 2020-07-15 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209946-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| COLESEVELAM HYDROCHLORIDE | COLESEVELAM HYDROCHLORIDE | Golden State Medical Supply, Inc. | c7058806-ad4f-6d5f-e053-2a95a90a35e8 | 2025-12-10 | Warnings, Adverse reactions | 209946 ANDA209946 51407-336 |
| Colesevelam hydrochloride | COLESEVELAM HYDROCHLORIDE | A-S Medication Solutions | 0f235408-e28d-4cce-b7f1-66bbe0e4534c | 2025-07-17 | Warnings, Adverse reactions | 209946 ANDA209946 |
| Colesevelam hydrochloride | COLESEVELAM HYDROCHLORIDE | A-S Medication Solutions | b48a7426-b513-4790-99a4-4f07d83318d7 | 2025-07-16 | Warnings, Adverse reactions | 209946 ANDA209946 |
| Colesevelam hydrochloride | COLESEVELAM HYDROCHLORIDE | Cranbury Pharmaceuticals, LLC | 5e50cc0c-03bc-444b-9d15-ea112bc0f91c | 2024-07-31 | Warnings, Adverse reactions | 209946 ANDA209946 27808-190 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 27808-190 | Colesevelam hydrochloride | Colesevelam hydrochloride | Tris Pharma Inc | ANDA | Current |
| 27808-190 | Colesevelam hydrochloride | Colesevelam hydrochloride | Tris Pharma Inc | ANDA | Current |
| 27808-190 | Colesevelam hydrochloride | Colesevelam hydrochloride | Tris Pharma Inc | ANDA | Current |
| 27808-190 | Colesevelam | Colesevelam | Tris Pharma Inc | ANDA | Current |
| 27808-190 | Colesevelam hydrochloride | Colesevelam hydrochloride | Tris Pharma Inc | ANDA | Current |
| 51407-336 | Colesevelam hydrochloride | Colesevelam hydrochloride | Golden State Medical Supply, Inc. | ANDA | Current |
| 51407-336 | Colesevelam hydrochloride | Colesevelam hydrochloride | Golden State Medical Supply, Inc. | ANDA | Current |